Effects of inhaled juniper volatile oil in amyloid beta (1-42)-induced anxiety and depression in laboratory rats
Corresponding Author
Lucian Hritcu
Department of Biology, Alexandru Ioan Cuza University of Iasi, Bd. Carol I, No.11, 700506 Romania
Correspondence to: Lucian Hritcu, Department of Biology, Alexandru Ioan Cuza University of Iasi, Bd. Carol I, No. 11, 700506, Romania. E-mail: [email protected]Search for more papers by this authorMonica Hancianu
Faculty of Pharmacy, University of Medicine and Pharmacy ‘Gr. T. Popa’, 16 University Str., Iasi, 700117 Romania
Search for more papers by this authorMarius Mihasan
Department of Biology, Alexandru Ioan Cuza University of Iasi, Bd. Carol I, No.11, 700506 Romania
Search for more papers by this authorOana Cioanca
Faculty of Pharmacy, University of Medicine and Pharmacy ‘Gr. T. Popa’, 16 University Str., Iasi, 700117 Romania
Search for more papers by this authorCorresponding Author
Lucian Hritcu
Department of Biology, Alexandru Ioan Cuza University of Iasi, Bd. Carol I, No.11, 700506 Romania
Correspondence to: Lucian Hritcu, Department of Biology, Alexandru Ioan Cuza University of Iasi, Bd. Carol I, No. 11, 700506, Romania. E-mail: [email protected]Search for more papers by this authorMonica Hancianu
Faculty of Pharmacy, University of Medicine and Pharmacy ‘Gr. T. Popa’, 16 University Str., Iasi, 700117 Romania
Search for more papers by this authorMarius Mihasan
Department of Biology, Alexandru Ioan Cuza University of Iasi, Bd. Carol I, No.11, 700506 Romania
Search for more papers by this authorOana Cioanca
Faculty of Pharmacy, University of Medicine and Pharmacy ‘Gr. T. Popa’, 16 University Str., Iasi, 700117 Romania
Search for more papers by this authorAbstract
Juniper volatile oil is extracted from Juniperus communis L., of the Cupressaceae family, also known as common juniper. Also, in aromatherapy the juniper volatile oil is used against anxiety, nervous tension and stress-related conditions. The present study analysed the possible anxiolytic, antidepressant and antioxidant properties of the juniper volatile oil in beta-amyloid (1-42) rat model of Alzheimer's disease. The anxiolytic- and antidepressant-like effects of the juniper volatile oil were studied by means of in vivo (elevated plus-maze and forced swimming tests) approaches. Also, the antioxidant activity in the amygdala was assessed using superoxide dismutase, glutathione peroxidase and catalase specific activities, the total content of the reduced glutathione, protein carbonyl and malondialdehyde levels. The beta-amyloid (1-42)-treated rats exhibited the following: decrease of the exploratory activity, the percentage of the time spent and the number of entries in the open arm within elevated plus-maze test and decrease of swimming time and increase of immobility time within forced swimming test. Inhalation of the juniper volatile oil significantly exhibited anxiolytic- and antidepressant-like effects and also antioxidant potential. Our results suggest that the juniper volatile oil inhalation ameliorates beta-amyloid (1-42)-induced anxiety and depression and attenuated oxidative stress in the rat amygdala. Copyright © 2015 John Wiley & Sons, Ltd.
References
- 1E. J. Jeong, H. K. Lee, K. Y. Lee, B. J. Jeon, D. H. Kim, J.-H. Park, J.-H. Song, J. Huh, J.-H. Lee, S. H. Sung. J. Ethnopharmacol. 2013, 146, 347.
- 2Y. Huang, L. Mucke. Cell 2012, 148, 1204.
- 3R. J. Bateman, C. Xiong, T. L. S. Benzinger, A. M. Fagan, A. Goate, N. C. Fox, D. S. Marcus, N. J. Cairns, X. Xie, T. M. Blazey, D. M. Holtzman, A. Santacruz, V. Buckles, A. Oliver, K. Moulder, P. S. Aisen, B. Ghetti, W. E. Klunk, E. McDade, R. N. Martins, C. L. Masters, R. Mayeux, J. M. Ringman, M. N. Rossor, P. R. Schofield, R. A. Sperling, S. Salloway, J. C. Morris. N. Engl. J. Med. 2012, 367, 795.
- 4T. Tan, J. Xie, T. Liu, X. Chen, X. Zheng, Z. Tong, X. Tian. Exp. Gerontol. 2013, 48, 786.
- 5R. Ashley, T. Harroun, T. Hauss, K. Breen, J. Bradshaw. BMC Struct. Biol. 2006, 6, 21.
- 6C. Ballard, A. Corbett. CNS Drugs 2010, 24, 729.
- 7J. Cerejeira, L. Lagarto, E. Mukaetova-Ladinska. Front Neurol. 2012, 3, 73.
- 8Y. Freund-Levi, H. Basun, T. Cederholm, G. Faxén-Irving, A. Garlind, M. Grut, I. Vedin, J. Palmblad, L.-O. Wahlund, M. Eriksdotter-Jönhagen. Int. J. Geriatr. Psychiatry 2008, 23, 161.
- 9T. Hwang, D. Masterman, F. Ortiz, L. Fairbanks, J. Cummings. Alzheimer Dis. Assoc. Disord. 2004, 18, 17.
- 10H. Braak, E. Braak. Acta. Neuropathol. (Berl) 1991, 82, 239.
- 11B. Hyman, G. Van Hoesen, A. Damasio. Neurology 1990, 40, 1721.
- 12J. España, L. Giménez-Llort, J. Valero, A. Miñano, A. Rábano, J. Rodriguez-Alvarez, F. LaFerla, S. Ca. Biol. Psychiatry 2010, 67, 513.
- 13A. L. Lublin, S. Gandy. Mt. Sinai J. Med. 2010, 77, 43.
- 14S. Wuwongse, R. C.-C. Chang, A. C. K. Law. Prog. Neurobiol. 2010, 91, 362.
- 15P. J. Seignourel, M. E. Kunik, L. Snow, N. Wilson, M. Stanley. Clin. Psychol. Rev. 2008, 28, 1071.
- 16F. Caraci, A. Copani, F. Nicoletti, F. Drago. Eur. J. Pharmacol. 2010, 626, 64.
- 17P. Martorell, E. Bataller, S. Llopis, N. Gonzalez, B. Álvarez, F. Montón, P. Ortiz, D. Ramón, S. Genovés. PLoS One 2013, 8, e63283.
- 18D. E. Allen, G. Hatfield. Medicinal plants in folk tradition. An ethnobotany of Britain & Ireland. Timer Press: Cambridge, 2004.
- 19M. M. Lesjak, I. N. Beara, D. Z. Orčić, G. T. Anačkov, K. J. Balog, M. M. Francišković, N. M. Mimica-Dukić. Food Chem. 2011, 124, 850.
- 20N. Miceli, A. Trovato, P. Dugo, F. Cacciola, P. Donato, A. Marino, V. Bellinghieri, T. M. La Barbera, A. Güvenç, M. F. Taviano. J. Agric. Food Chem. 2009, 57, 6570.
- 21E. K. Akkol, A. Güvenç, E. Yesilada. J. Ethnopharmacol. 2009, 125, 330.
- 22M. Öztürk, İ. Tümen, A. Uǧur, F. Aydoǧmuş-Öztürk, G. Topçu. J. Sci. Food Agric. 2011, 91, 867.
- 23L. Moreno, R. Bello, B. Beltrán, S. Calatayud, E. Primo-Yúfera, J. Esplugues. Pharmacol. Toxicol. 1998, 82, 108.
- 24O. Cioanca, C. Mircea, A. Trifan, A. Aprotosoaie, L. Hritcu, M. Hancianu. FARMACIA 2014, 62, 506.
- 25R. P. Adams. Identification of essential oil by Gas Chromatography/Mass Spectroscopy. Allured Publishing Corporation: Carol Stream, Illinois, 2007.
- 26S. E. Laursen, J. K. Belknap. J. Pharmacol. Methods 1986, 16, 355.
- 27G. Paxinos, S. Watson. The rat brain in stereotaxic coordinates. Academic Press: San Diego, 2005.
- 28V. M. Linck, A. L. da Silva, M. Figueiró, E. B. Caramão, P. R. H. Moreno, E. Elisabetsky. Phytomedicine 2010, 17, 679.
- 29Y. Hayashi, S. Sogabe, Y. Hattori, J. Tanaka. Neurosci. Lett. 2012, 531, 166.
- 30R. J. Rodgers, A. Dalvi. Neurosci. Biobehav. Rev. 1997, 21, 801.
- 31J. F. Cryan, A. Markou, I. Lucki. Trends Pharmacol. Sci. 2002, 23, 238.
- 32M. Campos, E. Fernandes, J. Ferreira, A. S. Santos, J. Calixto. Psychopharmacol. (Berl) 2005, 182, 45.
- 33C. Winterbourn, R. Hawkins, M. Brian, R. Carrell. J. Lab. Clin. Med. 1975, 85, 337.
- 34M. Sharma, Y. Gupta. Life Sci. 2002, 7, 2489.
- 35A. Sinha. Anal. Biochem. 1972, 47, 389.
- 36A. Fukuzawa, A. Tokumura. J. Nutr. Sci. Vitaminol. (Tokyo) 1976, 22, 405.
- 37C. Oliver, B. Ahn, E. Moerman, S. Goldstein, E. Stadtman. J. Biol. Chem. 1987, 262, 5488.
- 38S. Luo, N. Wehr. Redox Rep. 2009, 14, 159.
- 39H. Ohkawa, N. Ohishi, K. Yagi. Anal. Biochem. 1979, 95, 351.
- 40P. Smith, R. Krohn, G. Hermanson, A. Mallia, F. Gartner, M. Provenzano, E. Fujimoto, N. Goeke, B. Olson, D. Klenk. Anal. Biochem. 1985, 150, 76.
- 41T. Satou, S. Murakami, M. Matsuura, S. Hayashi, K. Koike. Nat. Prod. Commun. 2010, 5, 143.
- 42A. Blainski, V. K. Piccolo, J. C. P. Mello, R. M. W. de Oliveira. J. Ethnopharmacol. 2010, 128, 541.
- 43V. Hajhashemi, M. Rabbani, A. Ghanadi, E. Davari. Clinics 2010, 65, 1037.
- 44O. Cioanca, L. Hritcu, M. Mihasan, A. Trifan, M. Hancianu. Physiol. Behav. 2014, 131, 68.
- 45L. Brunton, J. Lazo, K. Parker. Goodman & Gilman's the pharmacological basis of therapeutics. McGraw-Hill: New York, 2006.
- 46M. Emamghoreishi, M. Khasaki, M. F. Aazam. J. Ethnopharmacol. 2005, 96, 365.
- 47S. L. Guzmán-Gutiérrez, R. Gómez-Cansino, J. C. García-Zebadúa, N. C. Jiménez-Pérez, R. Reyes-Chilpa. J. Ethnopharmacol. 2012, 143, 673.
- 48H. Aoshima, K. Hamamoto. Biosci. Biotechnol. Biochem. 1999, 63, 743.
- 49R. Porsolt, A. Bertin, M. Jalfre. Arch. Int. Pharmacodyn. Ther. 1977, 229, 327.
- 50O. Caspani, M.-C. Reitz, A. Ceci, A. Kremer, R.-D. Treede. Pharmacol. Biochem. Behav. 2014, 124, 290.
- 51D. Butterfield, D. Boyd-Kimball. Brain Pathol. 2004, 14, 426.
- 52D. A. Butterfield. Springer: London, 2007; 83.
- 53R. Liu, I. Y. Liu, X. Bi, R. F. Thompson, S. R. Doctrow, B. Malfroy, M. Baudry. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 8526.
- 54E. Stadtman. Science 1992, 257, 1220.
- 55J. H. Jhoo, H.-C. Kim, T. Nabeshima, K. Yamada, E.-J. Shin, W.-K. Jhoo, W. Kim, K.-S. Kang, S. A. Jo, J. I. Woo. Behav. Brain Res. 2004, 155, 185.
- 56P. Lu, T. Mamiya, L. L. Lu, A. Mouri, L. B. Zou, T. Nagai, M. Hiramatsu, T. Ikejima, T. Nabeshima. Br. J. Pharmacol. 2009, 157, 1270.
- 57W. R. Markesbery, M. A. Lovell. Neurobiol. Aging 1998, 19, 33.